Sequoia Pharma Raises $35 Million

Sequoia Pharmaceuticals Inc., a Gaithersburg, Md.-based drug developer focused on the treatment of drug-resistant HIV infections, has raised $35 million in Series C funding. The Wellcome Trust led the deal, and was joined by fellow existing shareholders Healthcare Venture, Sofinnova Partners and Aberdare Ventures. New backer MedImmune Ventures also participated.